VANCOUVER, British Columbia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (the “Company” or “Chemesis”), is pleased to announce it will be entering into
the cannabis infused beverages market. Chemesis will leverage licences and assets it has recently acquired to build out production,
storage, and a transportation network for its cannabis infused beverages. The cannabis beverages category includes sports drinks,
teas, sodas, coffees, shots, water, and other health and wellness beverages.
With cannabis sales projected to triple from approximately $5.4 billion USD in 2015, to $16 billion USD in 2020,
according to a market research, Chemesis sees a significant growing opportunity in the beverages market1. Entering into
the cannabis beverages market is the next logical step for the Company, as its current facilities and licenses allow this to be
accomplished in a relatively short period of time. The Company can accomplish this by leveraging its state licenses for production,
distribution, and transportation. Chemesis intends to provide white labelling services for companies, as well as introducing
beverages for its own brands. Chemesis will be using the recently acquired Desert Zen Fulfillment facility for this expansion and anticipates products to be launched in Q1
2019.
“Entering into the cannabis infused beverage market is an extremely important step for Chemesis,” said CEO Edgar
Montero. “The cannabis market is expanding into more product categories, and Chemesis is identifying opportunities that will build
long term value and consistent revenues. Our existing licenses and facilities will allow us to expand our portfolio of products
without the added regulatory delays. The company will continue to ensure it expands and creates a footprint in markets and product
spaces that align with our ambitious business plan.”
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently
operating within Puerto Rico, and California.
Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution, and
retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective production and distribution of its
products. In addition, Chemesis leverages exclusive brands and partnerships and uses the highest quality extraction methods, to
provide consumers with quality cannabis products.
Chemesis will add shareholder value by exploring opportunities in emerging markets while consistently delivering
quality product to its consumers from seed to sale.
ON BEHALF OF THE BOARD OF DIRECTORS
Edgar Montero
CEO and Director
INVESTOR RELATIONS:
ir@chemesis.com
www.chemesis.com
1 (604) 398-3378
1 Reuters
Forward-Looking Information: This news release contains "forward-looking
information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and
future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the
expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will
prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking
statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially
from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will
vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as
required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or
forward-looking information in this news release. Although the Company believes that the expectations reflected in the
forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no
reference to profitability based on sales reported. The statements in this news release are made as of the date of this
release.
The CSE has not reviewed, approved or disapproved the content of this press release